Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2+
G⍺<sub>o</sub>, the alpha subunit of the most abundant heterotrimeric G protein in the brain, mediates signaling by opioids and by many neuromodulators to inhibit neural function. An open question is whether activated G⍺<sub>o</sub>-GTP directly binds to and regulates effector molecules, like all other animal G⍺ proteins, or if it signals solely by releasing Gβγ subunits. Using mouse brain lysates as native source of G⍺<sub>o</sub> and its potential effectors, we analyzed immunopurified G⍺<sub>o</sub> protein complexes by mass spectrometry. Pre-activating G⍺<sub>o</sub> in the lysates with GTPγS resulted in a ∼6-fold increase in the amount of the small G protein GTPase activators RASA3 and RASA2 in the purified complexes, the largest increase among all G⍺<sub>o</sub>-associated proteins, making RASA2/3 candidate G⍺<sub>o</sub> effectors. Using purified recombinant proteins, we found that RASA3 binds directly to G⍺<sub>o</sub>-GTPγS more strongly than it does to G⍺<sub>o</sub>-GDP. We also found that the addition of Ca<sup>2+</sup>, a second messenger produced by the G⍺<sub>q</sub> pathway that opposes G⍺<sub>o</sub> signaling, strengthened binding of RASA3 to G⍺<sub>o</sub>-GDP. A C-terminal fragment of RASA3 containing a predicted Ca<sup>2+</sup> site was sufficient to bind G⍺<sub>o</sub>, albeit more weakly and without a preference for the activated state of G⍺<sub>o</sub>. We present a model in which RASA3 could mediate G⍺<sub>o</sub> signaling using two distinct G⍺<sub>o</sub>-binding sites: one on full-length RASA3 that preferentially binds active G⍺<sub>o</sub>-GTP and a second on the RASA3 C terminus that binds inactive G⍺<sub>o</sub> in the presence of Ca<sup>2+</sup>.
Authors
- TuKiet T. Lam (ORCID: https://orcid.org/0000-0002-4850-3462)
- Andrew Olson (ORCID: https://orcid.org/0000-0001-8882-3359)
- Michael R. Koelle (ORCID: https://orcid.org/0000-0001-9486-8481)
- Juliana E Gentile (ORCID: https://orcid.org/0000-0002-8389-4489)
- H. Bell
Institutions
- Yale University (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.jbc.2025.110999
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yale University
- National Institutes of Health
- National Institute on Drug Abuse